6th Swiss Industrial Chemistry Symposium
30. January 2026, Biozentrum Basel
6th Swiss Industrial Chemistry Symposium 2026
30. January 2026,Biozentrum Basel
Program
Download Booklet: Login required
08.30
Registration and morning coffee
09.00
Welcome Message
Session 1 - Chair: Dr. Hayley Binch, F. Hoffmann-La Roche Ltd
09.15
Dr. Henrik Moebitz, Novartis
SCS Senior Industrial Science Award Lecture 2025
«Adventures in chemical space»
09.45
Dr. Fides Benfatti and Dr. Federico Dapiaggi, Syngenta
«Target-Based Design and Hit to Lead Optimization of Pyrimidinylpyrazole Insecticides»
10.15
Coffee Break
Session 2 - Chair: Dr. René Wyler, Novartis Pharma AG
10.45
Dr. Lorena De Luca, Givaudan
«AmbreXolideTM: Synthesis via Olefin Metathesis»
11.15
Dr. Rafael Bermeo Malo, and Dr. John Lopez, Novartis
«Radioligand Therapy tales: from Discovery to Development»
11.45
Dr. Lionel Saudan, dsm-firmenich
«Hydrogenation and Hydroformylation Reactions for the Synthesis of New Perfumery Ingredients»
12.15
Lunch Break
Poster Session: max. 50 posters will be accepted. Abstract submission until Dec 15, 2025
Exhibition and Networking
Session 3 - Chair: Dr. Sarah Sulzer, Syngenta Crop Protection AG
14.00
Dr. Thomas Debnar, Siegfried
«Sustainability by Process Design – Development of a 3-Step Domino-Sequence en route to buprenorphine»
14.20
Dr. Michal Shoshan, metaLead Therapeutics AG
«Short peptides as next-generation chelating agents for treating Wilson disease»
14.40
Dr. Alessandro Castrogiovanni and Dr. Osvaldo Bortone, Merck
«An end-to-end robotic platform for high-throughput formulation development of biologics»
15.00
Dr. Irene Malpartida, Deasyl
«Mechanochemical Synthesis and Production Scale-up for Glycerol Valorisation Products»
15.20
Dr. Trung Cao, Cilag
«Driving Sustainability in the API Early Development Space»
15.40
Coffee Break
Session 4 - Chair: Dr. Stefan Abele, Pharvaris GmbH
16.10
Dr. Dominique Roberge, Lonza
«Innovative Journey to Continuous-Flow Industrialization»
16.40
Dr. Daniel Hunziker and Dr. Serena Fantasia, Roche
«Discovery and process development of Mosperafenib: the next-generation brain permeable, paradox breaker BRAF inhibitor»
17.10
Ceremony Best Presentation Awards
3x 2min pitches of the winners
17.30
Aperitif and networking